https://doi.org/10.4081/monaldi.2021.1816
The initial experience of COVID-19 vaccination from a tertiary care centre of India
Submitted: February 23, 2021
Accepted: March 19, 2021
Published: March 31, 2021
Accepted: March 19, 2021
Abstract Views: 4652
PDF: 2476
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
To the Editor
Drugs Controller General of India (DCGI) has approved the Bharat biotech vaccine against COVID-19, which is a locally manufactured inactivated vaccine named ''COVAXIN'' in collaboration with the Indian council of medical research (ICMR) on 3rd January 2021 for emergency use along with the "Covishield" Oxford-AstraZeneca vaccine manufactured locally by the Serum Institute of India...
*The Safdarjung COVID-19 Vaccination group:
KR Meena (Professor, Paediatrics), U Venkatesh (Assistant Professor, Community Medicine), Pushpa Kumari (Associate Professor, Medicine), Sonal Burman (Specialist, Medicine), Neeraj Kumar Gupta (Professor and Head, Pulmonary Medicine), Nitesh Gupta (Assistant Professor, Pulmonary Medicine), Rohit Kumar (Assistant Professor, Pulmonary Medicine), Swetabh Purohit (Senior resident, Pulmonary Medicine), Arjun Ramaswamy (Senior resident, Pulmonary Medicine)
Ministry of Health and Family Welfare. Press statement by the Drugs Controller General of India (DCGI) on restricted emergency approval of COVID-19 virus vaccine. Jan 3, 2021. Accessed: January 5, 2021. Available from: https://pib.gov.in/PressReleseDetail.aspx?PRID=1685761
Ella R, Vadrevu KM, Jogdand H, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis 2021;21:39-51.
DOI: https://doi.org/10.1016/S1473-3099(20)30831-8
Ella R, Reddy S, Jogdand H, et al. Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report. medRxiv 2020.12.21.20248643.
DOI: https://doi.org/10.1101/2020.12.21.20248643
The Hindu [Internet]. Coronavirus. Covaxin efficacy is 81%, works against variants. Accessed: 18 March 2021. Available from: Downloaded from https://www.thehindu.com/sci-tech/health/bharat-biotech-says-covid-19-vaccine-shows-81-interim-efficacy/article33980224.ece
Government of India. Operational Guideline COVID-19 Vaccines [Internet]. New Delhi; 2021. Accessed: 22 February 2021. Available from: https://www.mohfw.gov.in/pdf/COVID19VaccineOG111Chapter16.pdf
The Times of India [Internet]. Covid-19: India vaccinates 54.7% healthcare workers registered on CoWin platform. Accessed: 22 February 2021. Available from: https://timesofindia.indiatimes.com/india/covid-19-india-vaccinates-54-7-healthcare-workers-registered-on-cowin-platform/articleshow/80725869.cms
WHO. Classification of AEFIS. Accessed: 22 February 2021. Available from: https://vaccine-safety-training.org/classification-of-aefis.html
How to Cite
Srivastava, RK, Pranav Ish, and *Safdarjung COVID-19 Vaccination group. 2021. “The Initial Experience of COVID-19 Vaccination from a Tertiary Care Centre of India”. Monaldi Archives for Chest Disease 91 (4). https://doi.org/10.4081/monaldi.2021.1816.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Sunny Kumar, Saurabh Mehra, Mrinal Sircar, Onkar Jha, Rajesh Gupta, Seema Sinha, Ravneet Kaur, Evaluation of the efficacy of convalescent plasma in moderate to severe COVID-19 during 2020-2021: a retrospective observational study , Monaldi Archives for Chest Disease: Early Access
- Gaukhar Kurmanova, Almas Zhanaev, Akzharkyn Kaldybek, Balkiya Abdrakhmanova, Almira Akparova, Impact of the COVID-19 pandemic on the clinical features of patients with chronic obstructive pulmonary disease: an observational cross-sectional study , Monaldi Archives for Chest Disease: Early Access
- Tiziana Ciarambino, Elena Barbagelata, Graziamaria Corbi, Immacolata Ambrosino, Cecilia Politi, Franco Lavalle, Anna Ruggieri, Annamaria Moretti, Gender differences in vaccine therapy: where are we in COVID-19 pandemic? , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- Ashish Pundhir, Abhishek Jaiswal, Poonam Kushwaha, Akhil Dhanesh Goel, Anju Gahlot, Lakshmi Singh, Manmeet Kaur, A cross-sectional study on COVID-19 vaccine hesitancy in peri-urban areas in Kanpur, Uttar Pradesh, India , Monaldi Archives for Chest Disease: Vol. 94 No. 1 (2024)
- Roberto Carlon, Armando Olivieri, Luca Benacchio, Mario Zanchetta, Short and medium term functional capacity after single cycle of controlled physical training in subjects with claudication , Monaldi Archives for Chest Disease: Vol. 70 No. 2 (2008): Cardiac series
- F. Frati, C. Incorvaia, F. Marcucci, L. Sensi, G. Di Cara, P. Puccinelli, S. Dal Bo, Dose dependence of efficacy but not of safety in sublingual immunotherapy , Monaldi Archives for Chest Disease: Vol. 65 No. 1 (2006): Pulmonary series
- R. D’Ippolito, A. Foresi, C. Castagnetti, S. Gesualdi, A. Castagnaro, E. Marangio, D. Olivieri, Indications for flexible fiberoptic bronchoscopy and its safety in the very elderly , Monaldi Archives for Chest Disease: Vol. 67 No. 1 (2007): Pulmonary series
- Roberto Valle, Nadia Aspromonte, Emanuele Carbonieri, Giorgio De Michele, Giuseppe Di Tano, Prospero Giovinazzo, Roberta Cioè, Tiziana Di Giacomo, Loredano Milani, Federica Noventa, Mario Chiatto, BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure , Monaldi Archives for Chest Disease: Vol. 68 No. 3 (2007): Cardiac series
- Matteo Vigna, Piero Ceriana, Mara Santomassimo, Michele Vitacca, Mauro Maniscalco, Nicolino Ambrosino, Effects of pulmonary rehabilitation in survivors of severe acute respiratory syndrome coronavirus 2. Role of vaccination , Monaldi Archives for Chest Disease: Vol. 94 No. 3 (2024)
- Domenico Galzerano, Claudio Pragliola, Mohamed Al Admawi, Mario Mallardo, Sara Di Michele, Carlo Gaudio, The role of 3D echocardiographic imaging in the differential diagnosis of an atypical left atrial myxoma , Monaldi Archives for Chest Disease: Vol. 88 No. 3 (2018)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
